Premium
Sequoia Capital has exited its eight-year-old investment in Hyderabad-based contract research and discovery services company GVK Biosciences by selling its entire stake to private equity firm ChrysCapital.Although there is no official communiqué on the deal, as per the approval note by the Foreign Investment Promotion Board (FIPB), the nodal government body ......
This is a Premium article. Please subscribe or log in to read the full story!
Here's a selection of our recent premium content.
Already a member? Click here to log in.
